Global Medical Non-ionic Contrast Agent Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Medical Non-ionic Contrast Agent market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Due to the improvement of the chemical structure, non-ionic contrast agents have two main advantages over ionic contrast agents: most of the adverse reactions of contrast agents are related to high osmosis and charging. The distinguishing feature of non-ionic contrast agents is low osmotic pressure. It is uncharged, so it will not destabilize the internal environment; non-ionic contrast agents have less impact on peripheral blood vessels, pulmonary circulation vessels and cardiac conduction systems, so there are fewer sequelae, and they can be used for cardiovascular angiography.
This report is a detailed and comprehensive analysis for global Medical Non-ionic Contrast Agent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Non-ionic Contrast Agent market size and forecasts, in consumption value ($ Million), sales quantity (K Liters), and average selling prices (US$/Liter), 2021-2032
Global Medical Non-ionic Contrast Agent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Liters), and average selling prices (US$/Liter), 2021-2032
Global Medical Non-ionic Contrast Agent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Liters), and average selling prices (US$/Liter), 2021-2032
Global Medical Non-ionic Contrast Agent market shares of main players, shipments in revenue ($ Million), sales quantity (K Liters), and ASP (US$/Liter), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Non-ionic Contrast Agent market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Medical Non-ionic Contrast Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Non-ionic Contrast Agent, with price, sales quantity, revenue, and global market share of Medical Non-ionic Contrast Agent from 2021 to 2026.
Chapter 3, the Medical Non-ionic Contrast Agent competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Non-ionic Contrast Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Non-ionic Contrast Agent market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Non-ionic Contrast Agent.
Chapter 14 and 15, to describe Medical Non-ionic Contrast Agent sales channel, distributors, customers, research findings and conclusion.
Due to the improvement of the chemical structure, non-ionic contrast agents have two main advantages over ionic contrast agents: most of the adverse reactions of contrast agents are related to high osmosis and charging. The distinguishing feature of non-ionic contrast agents is low osmotic pressure. It is uncharged, so it will not destabilize the internal environment; non-ionic contrast agents have less impact on peripheral blood vessels, pulmonary circulation vessels and cardiac conduction systems, so there are fewer sequelae, and they can be used for cardiovascular angiography.
This report is a detailed and comprehensive analysis for global Medical Non-ionic Contrast Agent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Non-ionic Contrast Agent market size and forecasts, in consumption value ($ Million), sales quantity (K Liters), and average selling prices (US$/Liter), 2021-2032
Global Medical Non-ionic Contrast Agent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Liters), and average selling prices (US$/Liter), 2021-2032
Global Medical Non-ionic Contrast Agent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Liters), and average selling prices (US$/Liter), 2021-2032
Global Medical Non-ionic Contrast Agent market shares of main players, shipments in revenue ($ Million), sales quantity (K Liters), and ASP (US$/Liter), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Non-ionic Contrast Agent market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Iopamidol Injection
- Iodixanol Injection
- Iohexol Injection
- Iopromide Injection
- Other
- CT Enhanced Scan
- Neurography
- Angiography
- Arthrography
- Other
- GE Healthcare
- Braco
- Bayer
- Guerbet
- Leriva
- Yangtze River Pharmaceutical (Group)
- Jiangsu Chia Tai-Tianqing Pharmaceutical
- Jiangsu Hengrui Pharmaceuticals
- Hainan Poly Pharm
- Beijing Beilu Pharmaceutical
- Zhejiang Starry Pharmaceutical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Medical Non-ionic Contrast Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Non-ionic Contrast Agent, with price, sales quantity, revenue, and global market share of Medical Non-ionic Contrast Agent from 2021 to 2026.
Chapter 3, the Medical Non-ionic Contrast Agent competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Non-ionic Contrast Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Non-ionic Contrast Agent market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Non-ionic Contrast Agent.
Chapter 14 and 15, to describe Medical Non-ionic Contrast Agent sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Medical Non-ionic Contrast Agent Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Iopamidol Injection
1.3.3 Iodixanol Injection
1.3.4 Iohexol Injection
1.3.5 Iopromide Injection
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Medical Non-ionic Contrast Agent Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 CT Enhanced Scan
1.4.3 Neurography
1.4.4 Angiography
1.4.5 Arthrography
1.4.6 Other
1.5 Global Medical Non-ionic Contrast Agent Market Size & Forecast
1.5.1 Global Medical Non-ionic Contrast Agent Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Medical Non-ionic Contrast Agent Sales Quantity (2021-2032)
1.5.3 Global Medical Non-ionic Contrast Agent Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare Medical Non-ionic Contrast Agent Product and Services
2.1.4 GE Healthcare Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 GE Healthcare Recent Developments/Updates
2.2 Braco
2.2.1 Braco Details
2.2.2 Braco Major Business
2.2.3 Braco Medical Non-ionic Contrast Agent Product and Services
2.2.4 Braco Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Braco Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Medical Non-ionic Contrast Agent Product and Services
2.3.4 Bayer Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bayer Recent Developments/Updates
2.4 Guerbet
2.4.1 Guerbet Details
2.4.2 Guerbet Major Business
2.4.3 Guerbet Medical Non-ionic Contrast Agent Product and Services
2.4.4 Guerbet Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Guerbet Recent Developments/Updates
2.5 Leriva
2.5.1 Leriva Details
2.5.2 Leriva Major Business
2.5.3 Leriva Medical Non-ionic Contrast Agent Product and Services
2.5.4 Leriva Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Leriva Recent Developments/Updates
2.6 Yangtze River Pharmaceutical (Group)
2.6.1 Yangtze River Pharmaceutical (Group) Details
2.6.2 Yangtze River Pharmaceutical (Group) Major Business
2.6.3 Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Product and Services
2.6.4 Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Yangtze River Pharmaceutical (Group) Recent Developments/Updates
2.7 Jiangsu Chia Tai-Tianqing Pharmaceutical
2.7.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Details
2.7.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
2.7.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
2.7.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
2.8 Jiangsu Hengrui Pharmaceuticals
2.8.1 Jiangsu Hengrui Pharmaceuticals Details
2.8.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.8.3 Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Product and Services
2.8.4 Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.9 Hainan Poly Pharm
2.9.1 Hainan Poly Pharm Details
2.9.2 Hainan Poly Pharm Major Business
2.9.3 Hainan Poly Pharm Medical Non-ionic Contrast Agent Product and Services
2.9.4 Hainan Poly Pharm Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Hainan Poly Pharm Recent Developments/Updates
2.10 Beijing Beilu Pharmaceutical
2.10.1 Beijing Beilu Pharmaceutical Details
2.10.2 Beijing Beilu Pharmaceutical Major Business
2.10.3 Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
2.10.4 Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Beijing Beilu Pharmaceutical Recent Developments/Updates
2.11 Zhejiang Starry Pharmaceutical
2.11.1 Zhejiang Starry Pharmaceutical Details
2.11.2 Zhejiang Starry Pharmaceutical Major Business
2.11.3 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
2.11.4 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Zhejiang Starry Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MEDICAL NON-IONIC CONTRAST AGENT BY MANUFACTURER
3.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Manufacturer (2021-2026)
3.2 Global Medical Non-ionic Contrast Agent Revenue by Manufacturer (2021-2026)
3.3 Global Medical Non-ionic Contrast Agent Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Medical Non-ionic Contrast Agent by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Medical Non-ionic Contrast Agent Manufacturer Market Share in 2025
3.4.3 Top 6 Medical Non-ionic Contrast Agent Manufacturer Market Share in 2025
3.5 Medical Non-ionic Contrast Agent Market: Overall Company Footprint Analysis
3.5.1 Medical Non-ionic Contrast Agent Market: Region Footprint
3.5.2 Medical Non-ionic Contrast Agent Market: Company Product Type Footprint
3.5.3 Medical Non-ionic Contrast Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Medical Non-ionic Contrast Agent Market Size by Region
4.1.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Region (2021-2032)
4.1.2 Global Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2032)
4.1.3 Global Medical Non-ionic Contrast Agent Average Price by Region (2021-2032)
4.2 North America Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
4.3 Europe Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
4.4 Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
4.5 South America Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
4.6 Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
5.2 Global Medical Non-ionic Contrast Agent Consumption Value by Type (2021-2032)
5.3 Global Medical Non-ionic Contrast Agent Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
6.2 Global Medical Non-ionic Contrast Agent Consumption Value by Application (2021-2032)
6.3 Global Medical Non-ionic Contrast Agent Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
7.2 North America Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
7.3 North America Medical Non-ionic Contrast Agent Market Size by Country
7.3.1 North America Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
7.3.2 North America Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
8.2 Europe Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
8.3 Europe Medical Non-ionic Contrast Agent Market Size by Country
8.3.1 Europe Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
8.3.2 Europe Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Medical Non-ionic Contrast Agent Market Size by Region
9.3.1 Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
10.2 South America Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
10.3 South America Medical Non-ionic Contrast Agent Market Size by Country
10.3.1 South America Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
10.3.2 South America Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Medical Non-ionic Contrast Agent Market Size by Country
11.3.1 Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Medical Non-ionic Contrast Agent Market Drivers
12.2 Medical Non-ionic Contrast Agent Market Restraints
12.3 Medical Non-ionic Contrast Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Medical Non-ionic Contrast Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medical Non-ionic Contrast Agent
13.3 Medical Non-ionic Contrast Agent Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medical Non-ionic Contrast Agent Typical Distributors
14.3 Medical Non-ionic Contrast Agent Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Medical Non-ionic Contrast Agent Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Iopamidol Injection
1.3.3 Iodixanol Injection
1.3.4 Iohexol Injection
1.3.5 Iopromide Injection
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Medical Non-ionic Contrast Agent Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 CT Enhanced Scan
1.4.3 Neurography
1.4.4 Angiography
1.4.5 Arthrography
1.4.6 Other
1.5 Global Medical Non-ionic Contrast Agent Market Size & Forecast
1.5.1 Global Medical Non-ionic Contrast Agent Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Medical Non-ionic Contrast Agent Sales Quantity (2021-2032)
1.5.3 Global Medical Non-ionic Contrast Agent Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare Medical Non-ionic Contrast Agent Product and Services
2.1.4 GE Healthcare Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 GE Healthcare Recent Developments/Updates
2.2 Braco
2.2.1 Braco Details
2.2.2 Braco Major Business
2.2.3 Braco Medical Non-ionic Contrast Agent Product and Services
2.2.4 Braco Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Braco Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Medical Non-ionic Contrast Agent Product and Services
2.3.4 Bayer Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bayer Recent Developments/Updates
2.4 Guerbet
2.4.1 Guerbet Details
2.4.2 Guerbet Major Business
2.4.3 Guerbet Medical Non-ionic Contrast Agent Product and Services
2.4.4 Guerbet Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Guerbet Recent Developments/Updates
2.5 Leriva
2.5.1 Leriva Details
2.5.2 Leriva Major Business
2.5.3 Leriva Medical Non-ionic Contrast Agent Product and Services
2.5.4 Leriva Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Leriva Recent Developments/Updates
2.6 Yangtze River Pharmaceutical (Group)
2.6.1 Yangtze River Pharmaceutical (Group) Details
2.6.2 Yangtze River Pharmaceutical (Group) Major Business
2.6.3 Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Product and Services
2.6.4 Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Yangtze River Pharmaceutical (Group) Recent Developments/Updates
2.7 Jiangsu Chia Tai-Tianqing Pharmaceutical
2.7.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Details
2.7.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
2.7.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
2.7.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
2.8 Jiangsu Hengrui Pharmaceuticals
2.8.1 Jiangsu Hengrui Pharmaceuticals Details
2.8.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.8.3 Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Product and Services
2.8.4 Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.9 Hainan Poly Pharm
2.9.1 Hainan Poly Pharm Details
2.9.2 Hainan Poly Pharm Major Business
2.9.3 Hainan Poly Pharm Medical Non-ionic Contrast Agent Product and Services
2.9.4 Hainan Poly Pharm Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Hainan Poly Pharm Recent Developments/Updates
2.10 Beijing Beilu Pharmaceutical
2.10.1 Beijing Beilu Pharmaceutical Details
2.10.2 Beijing Beilu Pharmaceutical Major Business
2.10.3 Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
2.10.4 Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Beijing Beilu Pharmaceutical Recent Developments/Updates
2.11 Zhejiang Starry Pharmaceutical
2.11.1 Zhejiang Starry Pharmaceutical Details
2.11.2 Zhejiang Starry Pharmaceutical Major Business
2.11.3 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
2.11.4 Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Zhejiang Starry Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MEDICAL NON-IONIC CONTRAST AGENT BY MANUFACTURER
3.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Manufacturer (2021-2026)
3.2 Global Medical Non-ionic Contrast Agent Revenue by Manufacturer (2021-2026)
3.3 Global Medical Non-ionic Contrast Agent Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Medical Non-ionic Contrast Agent by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Medical Non-ionic Contrast Agent Manufacturer Market Share in 2025
3.4.3 Top 6 Medical Non-ionic Contrast Agent Manufacturer Market Share in 2025
3.5 Medical Non-ionic Contrast Agent Market: Overall Company Footprint Analysis
3.5.1 Medical Non-ionic Contrast Agent Market: Region Footprint
3.5.2 Medical Non-ionic Contrast Agent Market: Company Product Type Footprint
3.5.3 Medical Non-ionic Contrast Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Medical Non-ionic Contrast Agent Market Size by Region
4.1.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Region (2021-2032)
4.1.2 Global Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2032)
4.1.3 Global Medical Non-ionic Contrast Agent Average Price by Region (2021-2032)
4.2 North America Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
4.3 Europe Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
4.4 Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
4.5 South America Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
4.6 Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
5.2 Global Medical Non-ionic Contrast Agent Consumption Value by Type (2021-2032)
5.3 Global Medical Non-ionic Contrast Agent Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
6.2 Global Medical Non-ionic Contrast Agent Consumption Value by Application (2021-2032)
6.3 Global Medical Non-ionic Contrast Agent Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
7.2 North America Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
7.3 North America Medical Non-ionic Contrast Agent Market Size by Country
7.3.1 North America Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
7.3.2 North America Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
8.2 Europe Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
8.3 Europe Medical Non-ionic Contrast Agent Market Size by Country
8.3.1 Europe Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
8.3.2 Europe Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Medical Non-ionic Contrast Agent Market Size by Region
9.3.1 Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
10.2 South America Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
10.3 South America Medical Non-ionic Contrast Agent Market Size by Country
10.3.1 South America Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
10.3.2 South America Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Medical Non-ionic Contrast Agent Market Size by Country
11.3.1 Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Medical Non-ionic Contrast Agent Market Drivers
12.2 Medical Non-ionic Contrast Agent Market Restraints
12.3 Medical Non-ionic Contrast Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Medical Non-ionic Contrast Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medical Non-ionic Contrast Agent
13.3 Medical Non-ionic Contrast Agent Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medical Non-ionic Contrast Agent Typical Distributors
14.3 Medical Non-ionic Contrast Agent Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Medical Non-ionic Contrast Agent Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Medical Non-ionic Contrast Agent Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. GE Healthcare Major Business
Table 5. GE Healthcare Medical Non-ionic Contrast Agent Product and Services
Table 6. GE Healthcare Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. GE Healthcare Recent Developments/Updates
Table 8. Braco Basic Information, Manufacturing Base and Competitors
Table 9. Braco Major Business
Table 10. Braco Medical Non-ionic Contrast Agent Product and Services
Table 11. Braco Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Braco Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Medical Non-ionic Contrast Agent Product and Services
Table 16. Bayer Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Bayer Recent Developments/Updates
Table 18. Guerbet Basic Information, Manufacturing Base and Competitors
Table 19. Guerbet Major Business
Table 20. Guerbet Medical Non-ionic Contrast Agent Product and Services
Table 21. Guerbet Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Guerbet Recent Developments/Updates
Table 23. Leriva Basic Information, Manufacturing Base and Competitors
Table 24. Leriva Major Business
Table 25. Leriva Medical Non-ionic Contrast Agent Product and Services
Table 26. Leriva Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Leriva Recent Developments/Updates
Table 28. Yangtze River Pharmaceutical (Group) Basic Information, Manufacturing Base and Competitors
Table 29. Yangtze River Pharmaceutical (Group) Major Business
Table 30. Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Product and Services
Table 31. Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Yangtze River Pharmaceutical (Group) Recent Developments/Updates
Table 33. Jiangsu Chia Tai-Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
Table 35. Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
Table 36. Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 38. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Jiangsu Hengrui Pharmaceuticals Major Business
Table 40. Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Product and Services
Table 41. Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 43. Hainan Poly Pharm Basic Information, Manufacturing Base and Competitors
Table 44. Hainan Poly Pharm Major Business
Table 45. Hainan Poly Pharm Medical Non-ionic Contrast Agent Product and Services
Table 46. Hainan Poly Pharm Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Hainan Poly Pharm Recent Developments/Updates
Table 48. Beijing Beilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Beijing Beilu Pharmaceutical Major Business
Table 50. Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
Table 51. Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Beijing Beilu Pharmaceutical Recent Developments/Updates
Table 53. Zhejiang Starry Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Zhejiang Starry Pharmaceutical Major Business
Table 55. Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
Table 56. Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Zhejiang Starry Pharmaceutical Recent Developments/Updates
Table 58. Global Medical Non-ionic Contrast Agent Sales Quantity by Manufacturer (2021-2026) & (K Liters)
Table 59. Global Medical Non-ionic Contrast Agent Revenue by Manufacturer (2021-2026) & (USD Million)
Table 60. Global Medical Non-ionic Contrast Agent Average Price by Manufacturer (2021-2026) & (US$/Liter)
Table 61. Market Position of Manufacturers in Medical Non-ionic Contrast Agent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 62. Head Office and Medical Non-ionic Contrast Agent Production Site of Key Manufacturer
Table 63. Medical Non-ionic Contrast Agent Market: Company Product Type Footprint
Table 64. Medical Non-ionic Contrast Agent Market: Company Product Application Footprint
Table 65. Medical Non-ionic Contrast Agent New Market Entrants and Barriers to Market Entry
Table 66. Medical Non-ionic Contrast Agent Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 68. Global Medical Non-ionic Contrast Agent Sales Quantity by Region (2021-2026) & (K Liters)
Table 69. Global Medical Non-ionic Contrast Agent Sales Quantity by Region (2027-2032) & (K Liters)
Table 70. Global Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2026) & (USD Million)
Table 71. Global Medical Non-ionic Contrast Agent Consumption Value by Region (2027-2032) & (USD Million)
Table 72. Global Medical Non-ionic Contrast Agent Average Price by Region (2021-2026) & (US$/Liter)
Table 73. Global Medical Non-ionic Contrast Agent Average Price by Region (2027-2032) & (US$/Liter)
Table 74. Global Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 75. Global Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 76. Global Medical Non-ionic Contrast Agent Consumption Value by Type (2021-2026) & (USD Million)
Table 77. Global Medical Non-ionic Contrast Agent Consumption Value by Type (2027-2032) & (USD Million)
Table 78. Global Medical Non-ionic Contrast Agent Average Price by Type (2021-2026) & (US$/Liter)
Table 79. Global Medical Non-ionic Contrast Agent Average Price by Type (2027-2032) & (US$/Liter)
Table 80. Global Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 81. Global Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 82. Global Medical Non-ionic Contrast Agent Consumption Value by Application (2021-2026) & (USD Million)
Table 83. Global Medical Non-ionic Contrast Agent Consumption Value by Application (2027-2032) & (USD Million)
Table 84. Global Medical Non-ionic Contrast Agent Average Price by Application (2021-2026) & (US$/Liter)
Table 85. Global Medical Non-ionic Contrast Agent Average Price by Application (2027-2032) & (US$/Liter)
Table 86. North America Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 87. North America Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 88. North America Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 89. North America Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 90. North America Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2026) & (K Liters)
Table 91. North America Medical Non-ionic Contrast Agent Sales Quantity by Country (2027-2032) & (K Liters)
Table 92. North America Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2026) & (USD Million)
Table 93. North America Medical Non-ionic Contrast Agent Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Europe Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 95. Europe Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 96. Europe Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 97. Europe Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 98. Europe Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2026) & (K Liters)
Table 99. Europe Medical Non-ionic Contrast Agent Sales Quantity by Country (2027-2032) & (K Liters)
Table 100. Europe Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe Medical Non-ionic Contrast Agent Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 103. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 104. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 105. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 106. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Region (2021-2026) & (K Liters)
Table 107. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Region (2027-2032) & (K Liters)
Table 108. Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2026) & (USD Million)
Table 109. Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value by Region (2027-2032) & (USD Million)
Table 110. South America Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 111. South America Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 112. South America Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 113. South America Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 114. South America Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2026) & (K Liters)
Table 115. South America Medical Non-ionic Contrast Agent Sales Quantity by Country (2027-2032) & (K Liters)
Table 116. South America Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2026) & (USD Million)
Table 117. South America Medical Non-ionic Contrast Agent Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 119. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 120. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 121. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 122. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2026) & (K Liters)
Table 123. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Country (2027-2032) & (K Liters)
Table 124. Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Medical Non-ionic Contrast Agent Raw Material
Table 127. Key Manufacturers of Medical Non-ionic Contrast Agent Raw Materials
Table 128. Medical Non-ionic Contrast Agent Typical Distributors
Table 129. Medical Non-ionic Contrast Agent Typical Customers
Table 1. Global Medical Non-ionic Contrast Agent Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Medical Non-ionic Contrast Agent Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. GE Healthcare Major Business
Table 5. GE Healthcare Medical Non-ionic Contrast Agent Product and Services
Table 6. GE Healthcare Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. GE Healthcare Recent Developments/Updates
Table 8. Braco Basic Information, Manufacturing Base and Competitors
Table 9. Braco Major Business
Table 10. Braco Medical Non-ionic Contrast Agent Product and Services
Table 11. Braco Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Braco Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Medical Non-ionic Contrast Agent Product and Services
Table 16. Bayer Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Bayer Recent Developments/Updates
Table 18. Guerbet Basic Information, Manufacturing Base and Competitors
Table 19. Guerbet Major Business
Table 20. Guerbet Medical Non-ionic Contrast Agent Product and Services
Table 21. Guerbet Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Guerbet Recent Developments/Updates
Table 23. Leriva Basic Information, Manufacturing Base and Competitors
Table 24. Leriva Major Business
Table 25. Leriva Medical Non-ionic Contrast Agent Product and Services
Table 26. Leriva Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Leriva Recent Developments/Updates
Table 28. Yangtze River Pharmaceutical (Group) Basic Information, Manufacturing Base and Competitors
Table 29. Yangtze River Pharmaceutical (Group) Major Business
Table 30. Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Product and Services
Table 31. Yangtze River Pharmaceutical (Group) Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Yangtze River Pharmaceutical (Group) Recent Developments/Updates
Table 33. Jiangsu Chia Tai-Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
Table 35. Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
Table 36. Jiangsu Chia Tai-Tianqing Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 38. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Jiangsu Hengrui Pharmaceuticals Major Business
Table 40. Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Product and Services
Table 41. Jiangsu Hengrui Pharmaceuticals Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 43. Hainan Poly Pharm Basic Information, Manufacturing Base and Competitors
Table 44. Hainan Poly Pharm Major Business
Table 45. Hainan Poly Pharm Medical Non-ionic Contrast Agent Product and Services
Table 46. Hainan Poly Pharm Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Hainan Poly Pharm Recent Developments/Updates
Table 48. Beijing Beilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Beijing Beilu Pharmaceutical Major Business
Table 50. Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
Table 51. Beijing Beilu Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Beijing Beilu Pharmaceutical Recent Developments/Updates
Table 53. Zhejiang Starry Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Zhejiang Starry Pharmaceutical Major Business
Table 55. Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Product and Services
Table 56. Zhejiang Starry Pharmaceutical Medical Non-ionic Contrast Agent Sales Quantity (K Liters), Average Price (US$/Liter), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Zhejiang Starry Pharmaceutical Recent Developments/Updates
Table 58. Global Medical Non-ionic Contrast Agent Sales Quantity by Manufacturer (2021-2026) & (K Liters)
Table 59. Global Medical Non-ionic Contrast Agent Revenue by Manufacturer (2021-2026) & (USD Million)
Table 60. Global Medical Non-ionic Contrast Agent Average Price by Manufacturer (2021-2026) & (US$/Liter)
Table 61. Market Position of Manufacturers in Medical Non-ionic Contrast Agent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 62. Head Office and Medical Non-ionic Contrast Agent Production Site of Key Manufacturer
Table 63. Medical Non-ionic Contrast Agent Market: Company Product Type Footprint
Table 64. Medical Non-ionic Contrast Agent Market: Company Product Application Footprint
Table 65. Medical Non-ionic Contrast Agent New Market Entrants and Barriers to Market Entry
Table 66. Medical Non-ionic Contrast Agent Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 68. Global Medical Non-ionic Contrast Agent Sales Quantity by Region (2021-2026) & (K Liters)
Table 69. Global Medical Non-ionic Contrast Agent Sales Quantity by Region (2027-2032) & (K Liters)
Table 70. Global Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2026) & (USD Million)
Table 71. Global Medical Non-ionic Contrast Agent Consumption Value by Region (2027-2032) & (USD Million)
Table 72. Global Medical Non-ionic Contrast Agent Average Price by Region (2021-2026) & (US$/Liter)
Table 73. Global Medical Non-ionic Contrast Agent Average Price by Region (2027-2032) & (US$/Liter)
Table 74. Global Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 75. Global Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 76. Global Medical Non-ionic Contrast Agent Consumption Value by Type (2021-2026) & (USD Million)
Table 77. Global Medical Non-ionic Contrast Agent Consumption Value by Type (2027-2032) & (USD Million)
Table 78. Global Medical Non-ionic Contrast Agent Average Price by Type (2021-2026) & (US$/Liter)
Table 79. Global Medical Non-ionic Contrast Agent Average Price by Type (2027-2032) & (US$/Liter)
Table 80. Global Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 81. Global Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 82. Global Medical Non-ionic Contrast Agent Consumption Value by Application (2021-2026) & (USD Million)
Table 83. Global Medical Non-ionic Contrast Agent Consumption Value by Application (2027-2032) & (USD Million)
Table 84. Global Medical Non-ionic Contrast Agent Average Price by Application (2021-2026) & (US$/Liter)
Table 85. Global Medical Non-ionic Contrast Agent Average Price by Application (2027-2032) & (US$/Liter)
Table 86. North America Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 87. North America Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 88. North America Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 89. North America Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 90. North America Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2026) & (K Liters)
Table 91. North America Medical Non-ionic Contrast Agent Sales Quantity by Country (2027-2032) & (K Liters)
Table 92. North America Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2026) & (USD Million)
Table 93. North America Medical Non-ionic Contrast Agent Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Europe Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 95. Europe Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 96. Europe Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 97. Europe Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 98. Europe Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2026) & (K Liters)
Table 99. Europe Medical Non-ionic Contrast Agent Sales Quantity by Country (2027-2032) & (K Liters)
Table 100. Europe Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe Medical Non-ionic Contrast Agent Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 103. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 104. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 105. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 106. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Region (2021-2026) & (K Liters)
Table 107. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity by Region (2027-2032) & (K Liters)
Table 108. Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value by Region (2021-2026) & (USD Million)
Table 109. Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value by Region (2027-2032) & (USD Million)
Table 110. South America Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 111. South America Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 112. South America Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 113. South America Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 114. South America Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2026) & (K Liters)
Table 115. South America Medical Non-ionic Contrast Agent Sales Quantity by Country (2027-2032) & (K Liters)
Table 116. South America Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2026) & (USD Million)
Table 117. South America Medical Non-ionic Contrast Agent Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Type (2021-2026) & (K Liters)
Table 119. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Type (2027-2032) & (K Liters)
Table 120. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Application (2021-2026) & (K Liters)
Table 121. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Application (2027-2032) & (K Liters)
Table 122. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Country (2021-2026) & (K Liters)
Table 123. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity by Country (2027-2032) & (K Liters)
Table 124. Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Medical Non-ionic Contrast Agent Raw Material
Table 127. Key Manufacturers of Medical Non-ionic Contrast Agent Raw Materials
Table 128. Medical Non-ionic Contrast Agent Typical Distributors
Table 129. Medical Non-ionic Contrast Agent Typical Customers
LIST OF FIGURES
Figure 1. Medical Non-ionic Contrast Agent Picture
Figure 2. Global Medical Non-ionic Contrast Agent Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Medical Non-ionic Contrast Agent Revenue Market Share by Type in 2025
Figure 4. Iopamidol Injection Examples
Figure 5. Iodixanol Injection Examples
Figure 6. Iohexol Injection Examples
Figure 7. Iopromide Injection Examples
Figure 8. Other Examples
Figure 9. Global Medical Non-ionic Contrast Agent Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Medical Non-ionic Contrast Agent Revenue Market Share by Application in 2025
Figure 11. CT Enhanced Scan Examples
Figure 12. Neurography Examples
Figure 13. Angiography Examples
Figure 14. Arthrography Examples
Figure 15. Other Examples
Figure 16. Global Medical Non-ionic Contrast Agent Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 17. Global Medical Non-ionic Contrast Agent Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 18. Global Medical Non-ionic Contrast Agent Sales Quantity (2021-2032) & (K Liters)
Figure 19. Global Medical Non-ionic Contrast Agent Price (2021-2032) & (US$/Liter)
Figure 20. Global Medical Non-ionic Contrast Agent Sales Quantity Market Share by Manufacturer in 2025
Figure 21. Global Medical Non-ionic Contrast Agent Revenue Market Share by Manufacturer in 2025
Figure 22. Producer Shipments of Medical Non-ionic Contrast Agent by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 23. Top 3 Medical Non-ionic Contrast Agent Manufacturer (Revenue) Market Share in 2025
Figure 24. Top 6 Medical Non-ionic Contrast Agent Manufacturer (Revenue) Market Share in 2025
Figure 25. Global Medical Non-ionic Contrast Agent Sales Quantity Market Share by Region (2021-2032)
Figure 26. Global Medical Non-ionic Contrast Agent Consumption Value Market Share by Region (2021-2032)
Figure 27. North America Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 32. Global Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 33. Global Medical Non-ionic Contrast Agent Consumption Value Market Share by Type (2021-2032)
Figure 34. Global Medical Non-ionic Contrast Agent Average Price by Type (2021-2032) & (US$/Liter)
Figure 35. Global Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 36. Global Medical Non-ionic Contrast Agent Revenue Market Share by Application (2021-2032)
Figure 37. Global Medical Non-ionic Contrast Agent Average Price by Application (2021-2032) & (US$/Liter)
Figure 38. North America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 39. North America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 40. North America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Country (2021-2032)
Figure 41. North America Medical Non-ionic Contrast Agent Consumption Value Market Share by Country (2021-2032)
Figure 42. United States Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 43. Canada Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 44. Mexico Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 45. Europe Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 46. Europe Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 47. Europe Medical Non-ionic Contrast Agent Sales Quantity Market Share by Country (2021-2032)
Figure 48. Europe Medical Non-ionic Contrast Agent Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 50. France Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 55. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 56. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity Market Share by Region (2021-2032)
Figure 57. Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value Market Share by Region (2021-2032)
Figure 58. China Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 61. India Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 65. South America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 66. South America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Country (2021-2032)
Figure 67. South America Medical Non-ionic Contrast Agent Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity Market Share by Country (2021-2032)
Figure 73. Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 75. Egypt Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 77. South Africa Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 78. Medical Non-ionic Contrast Agent Market Drivers
Figure 79. Medical Non-ionic Contrast Agent Market Restraints
Figure 80. Medical Non-ionic Contrast Agent Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Medical Non-ionic Contrast Agent in 2025
Figure 83. Manufacturing Process Analysis of Medical Non-ionic Contrast Agent
Figure 84. Medical Non-ionic Contrast Agent Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Medical Non-ionic Contrast Agent Picture
Figure 2. Global Medical Non-ionic Contrast Agent Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Medical Non-ionic Contrast Agent Revenue Market Share by Type in 2025
Figure 4. Iopamidol Injection Examples
Figure 5. Iodixanol Injection Examples
Figure 6. Iohexol Injection Examples
Figure 7. Iopromide Injection Examples
Figure 8. Other Examples
Figure 9. Global Medical Non-ionic Contrast Agent Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Medical Non-ionic Contrast Agent Revenue Market Share by Application in 2025
Figure 11. CT Enhanced Scan Examples
Figure 12. Neurography Examples
Figure 13. Angiography Examples
Figure 14. Arthrography Examples
Figure 15. Other Examples
Figure 16. Global Medical Non-ionic Contrast Agent Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 17. Global Medical Non-ionic Contrast Agent Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 18. Global Medical Non-ionic Contrast Agent Sales Quantity (2021-2032) & (K Liters)
Figure 19. Global Medical Non-ionic Contrast Agent Price (2021-2032) & (US$/Liter)
Figure 20. Global Medical Non-ionic Contrast Agent Sales Quantity Market Share by Manufacturer in 2025
Figure 21. Global Medical Non-ionic Contrast Agent Revenue Market Share by Manufacturer in 2025
Figure 22. Producer Shipments of Medical Non-ionic Contrast Agent by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 23. Top 3 Medical Non-ionic Contrast Agent Manufacturer (Revenue) Market Share in 2025
Figure 24. Top 6 Medical Non-ionic Contrast Agent Manufacturer (Revenue) Market Share in 2025
Figure 25. Global Medical Non-ionic Contrast Agent Sales Quantity Market Share by Region (2021-2032)
Figure 26. Global Medical Non-ionic Contrast Agent Consumption Value Market Share by Region (2021-2032)
Figure 27. North America Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 32. Global Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 33. Global Medical Non-ionic Contrast Agent Consumption Value Market Share by Type (2021-2032)
Figure 34. Global Medical Non-ionic Contrast Agent Average Price by Type (2021-2032) & (US$/Liter)
Figure 35. Global Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 36. Global Medical Non-ionic Contrast Agent Revenue Market Share by Application (2021-2032)
Figure 37. Global Medical Non-ionic Contrast Agent Average Price by Application (2021-2032) & (US$/Liter)
Figure 38. North America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 39. North America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 40. North America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Country (2021-2032)
Figure 41. North America Medical Non-ionic Contrast Agent Consumption Value Market Share by Country (2021-2032)
Figure 42. United States Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 43. Canada Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 44. Mexico Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 45. Europe Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 46. Europe Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 47. Europe Medical Non-ionic Contrast Agent Sales Quantity Market Share by Country (2021-2032)
Figure 48. Europe Medical Non-ionic Contrast Agent Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 50. France Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 55. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 56. Asia-Pacific Medical Non-ionic Contrast Agent Sales Quantity Market Share by Region (2021-2032)
Figure 57. Asia-Pacific Medical Non-ionic Contrast Agent Consumption Value Market Share by Region (2021-2032)
Figure 58. China Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 61. India Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 65. South America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 66. South America Medical Non-ionic Contrast Agent Sales Quantity Market Share by Country (2021-2032)
Figure 67. South America Medical Non-ionic Contrast Agent Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Medical Non-ionic Contrast Agent Sales Quantity Market Share by Country (2021-2032)
Figure 73. Middle East & Africa Medical Non-ionic Contrast Agent Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 75. Egypt Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 77. South Africa Medical Non-ionic Contrast Agent Consumption Value (2021-2032) & (USD Million)
Figure 78. Medical Non-ionic Contrast Agent Market Drivers
Figure 79. Medical Non-ionic Contrast Agent Market Restraints
Figure 80. Medical Non-ionic Contrast Agent Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Medical Non-ionic Contrast Agent in 2025
Figure 83. Manufacturing Process Analysis of Medical Non-ionic Contrast Agent
Figure 84. Medical Non-ionic Contrast Agent Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
